{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "LSE", "shortName": "NICOX SA NICOX ORD SHS", "longName": "Nicox S.A.", "messageBoardId": "finmb_131325", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChangePercent": 1.4027231, "regularMarketPrice": 0.59422, "marketState": "CLOSED", "fiftyTwoWeekHighChangePercent": -0.71154374, "fiftyTwoWeekLow": 0.0, "fiftyTwoWeekHigh": 2.06, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.167, "sharesOutstanding": 29588500, "bookValue": 1.405, "fiftyDayAverage": 0.7371832, "fiftyDayAverageChange": -0.14296323, "fiftyDayAverageChangePercent": -0.19393174, "twoHundredDayAverage": 1.3143618, "twoHundredDayAverageChange": -0.7201418, "twoHundredDayAverageChangePercent": -0.5479023, "marketCap": 172055, "priceToBook": 0.4229324, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.008219957, "regularMarketTime": 1683824943, "regularMarketDayHigh": 0.0, "regularMarketDayRange": "0.0 - 0.0", "regularMarketDayLow": 0.0, "regularMarketVolume": 13064, "regularMarketPreviousClose": 0.586, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "LSE", "financialCurrency": "EUR", "regularMarketOpen": 0.0, "averageDailyVolume3Month": 11307, "averageDailyVolume10Day": 4587, "fiftyTwoWeekLowChange": 0.59422, "fiftyTwoWeekRange": "0.0 - 2.06", "fiftyTwoWeekHighChange": -1.46578, "firstTradeDateMilliseconds": 1197878400000, "symbol": "0RCQ.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2405 Route Des Dolines Drakkar D", "city": "Valbonne", "zip": "06560", "country": "France", "phone": "33 4 97 24 53 00", "fax": "33 4 97 24 53 99", "website": "https://www.nicox.com", "industry": "", "sector": "", "longBusinessSummary": "Nicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating prostaglandin analog for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in phase 3 clinical trial. The company is also developing NCX 4251, a proprietary formulation of fluticasone for acute exacerbations of blepharitis that is in a Phase 2b clinical trial for the treatment of acute exacerbations of blepharitis; and NCX 1728.It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was founded in 1996 and is headquartered in Valbonne, France.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Michele  Garufi Ph.D.", "age": 68, "title": "Co-Founder & Director", "yearBorn": 1954, "fiscalYear": 2021, "totalPay": {"raw": 475450, "fmt": "475.45k", "longFmt": "475,450"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andreas Rutger Segerros M.B.A., M.Sc.", "age": 62, "title": "Chief Exec. Officer", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sandrine  Gestin", "age": 55, "title": "VP of Fin.", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Doug  Hubatsch", "age": 55, "title": "Exec. VP & Chief Scientific Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Emmanuelle  Pierry", "age": 53, "title": "Gen. Counsel & Head of Legal Affairs", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gavin M. Spencer", "age": 52, "title": "Exec. VP, Chief Bus. Officer & Head of Corp. Devel.", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ramesh  Krishnamoorthy", "title": "Sr. Director and Head of Late Stage CMC & Quality Control", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jose  Boyer", "title": "Consultant", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}